Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reduced-intensity conditioning therapy with fludarabine, idarubicin, busulfan and cytarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.

Leukemia research·2013

Same author

Effects of 3, 5, 3'-triiodothyronine (t3) and follicle stimulating hormone on apoptosis and proliferation of rat ovarian granulosa cells.

The Chinese journal of physiology·2013

Same author

Cardiogenic shock from acute ST-segment elevation myocardial infarction induced by severe multivessel coronary vasospasm.

European heart journal·2013

Same author

[Comparative study on effects of electroacupuncture stimulation of Shenmen (HT 7) and Taiyuan (LU 9) on P 300 of event-related potentials and brain electrical activity mapping in healthy young adults].

Zhen ci yan jiu = Acupuncture research·2013

Same author

MiR-215 modulates gastric cancer cell proliferation by targeting RB1.

Cancer letters·2013

Same author

Low glucose utilization and neurodegenerative changes caused by sodium fluoride exposure in rat's developmental brain.

Neuromolecular medicine·2013

Search research articles

Related Experiment Video

Updated: Dec 16, 2025

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

Recent advances in CAR-T cell engineering.

Ruihao Huang¹, Xiaoping Li¹, Yundi He¹

¹Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, 400037, China.

Journal of Hematology & Oncology

|July 4, 2020

Summary

Engineered chimeric antigen receptor T (CAR-T) cell therapy shows promise for treating relapsed cancers. Innovations in CAR-T cell structure and manufacturing are improving efficacy and overcoming resistance for better tumor treatment.

Keywords:

CAR-T cell therapy Hematological malignancies Immune therapy

More Related Videos

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

Related Experiment Videos

Last Updated: Dec 16, 2025

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

Area of Science:

Immunotherapy
Oncology
Biotechnology

Background:

Chimeric antigen receptor T (CAR-T) cell therapy is a key treatment for relapsed or refractory tumors, especially hematological malignancies.
Initial anti-CD19 CAR-T therapies show success but face challenges like relapse and resistance.
Advancements are needed to enhance CAR-T cell effectiveness and persistence.

Purpose of the Study:

To review recent innovations in CAR-T cell therapy.
To explore structural modifications and manufacturing improvements in CAR-T cells.
To highlight the potential of next-generation CAR-T cells in overcoming tumor microenvironment challenges.

Main Methods:

Review of recent scientific literature on CAR-T cell therapy.
Analysis of structural components: ectodomain, transmembrane domain, and endodomain.
Examination of manufacturing technologies and cell source improvements.

Main Results:

Fourth-generation and next-generation CAR-T cells demonstrate improved efficacy and persistence.
Structural innovations enhance CAR-T cell function.
Advanced manufacturing and cell sources contribute to better therapeutic prospects.

Conclusions:

Innovations in CAR-T cell structure and manufacturing are significantly improving therapeutic outcomes.
Next-generation CAR-T cells, especially when combined with immune modifiers, offer a powerful strategy against challenging tumors.
Future CAR-T cell therapy development is promising for overcoming limitations and expanding treatment applications.